Announcements

18 March 2025
Meet Us at the International Virus Bioinformatics Meeting 2025 (ViBioM2025), 13–15 May 2025, Lisbon, Portugal


MDPI will attend the International Virus Bioinformatics Meeting 2025 (ViBioM2025) as an exhibitor. This meeting will be held in Lisbon, Portugal, from 13 to 15 May 2025.

The International Virus Bioinformatics Meeting (ViBioM) is a pioneering conference uniting leading scientists at the intersection of virology and bioinformatics, fostering collaboration and innovation in the study of viruses.

As we navigate the rapidly changing landscape of viruses and their impact on human health and the broader ecosystem, it has become increasingly essential for virologists and bioinformaticians to work together. ViBioM2025 provides a dynamic platform for the exchange of knowledge, cutting-edge research, and groundbreaking discoveries. It will offer an excellent opportunity to present and discuss your research, (re)connect with colleagues and friends, and establish new collaborations. Its mission is to create an environment where both experts and newcomers can engage in meaningful discussions and build lasting connections. 

The scientific program will cover a wide array of topics, ensuring a comprehensive and enriching experience for all attendees.

The following MDPI journals will be represented at the conference:

  • Viruses;
  • Pathogens;
  • CIMB;
  • COVID;
  • J;
  • Microorganisms;
  • TropicalMed.

If you are planning to attend this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit https://evbc.uni-jena.de/events/vibiom2025/.

27 February 2025
Meet Us at the 19th Conference of the International Society of Travel Medicine (CISTM19), 11–15 May 2025, New Orleans, USA


Conference: 19th Conference of the International Society of Travel Medicine (CISTM19)
Organization: International Society of Travel Medicine
Date: 11–15 May 2025
Place: New Orleans, Louisiana, USA
Booth ID: #19

A number of MDPI journals will be attending CISTM19 as exhibitors. This meeting will be held in New Orleans, USA, from 11 to 15 May 2025.

CISTM19 is the premier gathering of approximately 1,100+ travel medicine specialists and practitioners to learn about the latest developments and new and innovative technologies, products, and services, as well as to contribute to the evolving field of travel medicine.

The following MDPI journals will be represented:

  • TropicalMed;
  • COVID;
  • Diseases;
  • Antibiotics;
  • Parasitologia;
  • Life;
  • Viruses;
  • Healthcare;
  • Vaccines;
  • Women;
  • Children;
  • Infectious Disease Reports;
  • Microorganisms;
  • Epidemiologia.

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.istm.org/event/cistm19/.

27 February 2025
More than 300 MDPI Journals Indexed in Web of Science

MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines. 

To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data. 

This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide. 

As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.

17 February 2025
MDPI Celebrates Excellence in Medical Research with Early Career Researcher Awards


MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.

Honoring Excellence in Research

The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:

Early Career Researcher (Postdoc) Award:

  • Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
  • Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
  • Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.

Early Career Researcher (Ph.D.) Award:

  • Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;
  • Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
  • Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.

Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.

Looking Ahead to 2025

Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.

Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.

5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2024 Annual Meeting – Beijing (15 January 2025)

You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.

Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.

This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.

I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.

“Our editorial teams represent MDPI at its finest”

I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.

Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.

MDPI Offices in China

While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.

While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.

We look forward to a year filled with continued collaboration, growth, and shared success.

“We remain committed to future growth in China”

Impactful Research

MDPI and Jisc Consortium Extend Open Access Agreement for 2025

I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.

Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.

Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.

A full list of participating institutions can be found here.

As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”

At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.

Inside MDPI

Visit to MDPI's Singapore office

During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.

Welcoming and Supporting New Team Members

“Experienced staff play an important role in mentoring new hires”

I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.

Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.

Building MDPI’s Positive Reputation

During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.

Connecting with the Singapore Marketing Team

I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow. 

During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.

Meeting with Prof. Dr. Manoj Gupta

Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.

Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.

Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.

During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.

PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!

 

Coming Together for Science

JAMS – Journal & Article Management System

I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.

With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.

“JAMS is a testament to our commitment to simplifying the publishing process”

Explore the new website here: jams.pub

It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.

Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.

JAMS was built to change that by adapting to the unique requirements of each publisher.

At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.

Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.

Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

What Sets JAMS Apart?

  • Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
  • End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
  • Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
  • Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
  • Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.

Partners Who Already Trust JAMS

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

Closing Thoughts

Visit to MDPI's Bangkok office

To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.

I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.

Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.

Engaging with Group Leads

“Group leads play an important role in creating a safe, positive environment”

During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.

To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.

University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)

We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.

Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.

This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.

“My time in Bangkok was productive and inspiring”

My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.

Stefan Tochev
Chief Executive Officer
MDPI AG

24 January 2025
Welcoming New Editorial Board Members of TropicalMed Joined in Q4 of 2024

We are pleased to announce that four new scholars were appointed as Editorial Board Members (EBMs) of TropicalMed (ISSN: 2414-6366) in the fourth quarter of 2024. We wish our new members success in both their research and their efforts to develop the journal.

Name: Dr. Alison Krentel
Affiliation: School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1N 6N5, Canada
Interests: neglected tropical diseases; public health; infectious diseases; global health; community engagement

Name: Prof. Dr. George Rutherford
Affiliation: Center for Global Strategic Information and Public Health Practice, Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California 94143-1224, USA
Interests: global health; public health; epidemiology and prevention of HIV/AIDS; tuberculosis; infectious diseases of public health importance

Name: Dr. Didier Ménard
Affiliation: Malaria Genetics and Resistance Team (MEGATEAM), UR 3073 - Pathogens Host Arthropods Vectors Interactions, Université de Strasbourg, F-67000 Strasbourg, France
Interests: malaria; P. falciparum; antimalarial drug resistance; artemisinin; genetics, evolution, transmission; P. vivax; host–pathogen interactions; epidemiology; public health; Southeast Asia; Africa; tropical disease

Name: Dr. John Waitumbi
Affiliation: WRAIR-Africa, Kenya Medical Research Institute, Basic Science Laboratory, Kisumu 40100, Kenya
Interests: molecular epidemiology; disease surveillance; One Health; wastewater; outbreak response

Further details about the Editorial Board of TropicalMed can be found at the following link: https://www.mdpi.com/journal/tropicalmed/editors.

TropicalMed is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the TropicalMed Editorial Office (tropicalmed@mdpi.com) and provide the following documents:

  • A full academic CV;
  • A short cover letter detailing your interest in the position.

TropicalMed Editorial Office

24 January 2025
Acknowledgment to the Reviewers of Tropical Medicine and Infectious Disease in 2024


The editorial team at Tropical Medicine and Infectious Disease (TropicalMed) extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, TropicalMed received 1666 review reports from 982 reviewers representing 89 countries and regions worldwide.

To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, TropicalMed expresses its sincere gratitude through an annual acknowledgment of reviewers.

We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:

Abdulkarim Jafar Karim Kurubaran Ganasegeran
Adam Whisnant Leandro Buffoni Perazzo
Adriaan Erasmus Basson Lilijana Kornhauser-Cerar
Adriano Cappellazzo Coelho Lizette Leonie Koekemoer
Ahmad Albattat Lorenzo Domenis
Ahmad Rushdi Shakri Lubomira Nikolaeva-Glomb
Ahmed Nawsher Alam Lucas Sousa Magalhães
Aimi Salihah Abdul Nasir Luis Alberto Sánchez-Vargas
Alberto Arnedo-Pena Luís Cardoso
Alberto Rizzo Luis Pablo Cruz Hervert
Aldemir Branco Oliveira-Filho Marc Vasse
Alexandra Rak Marco Fiore
Alexey Andreychev Maria Livia Ognean
Alicia Irene Arechavala Maria T. Solís-Soto
Amal Hosni Mariafrancesca Fiorentino
Amjad Islam Aqib Marine Wasniewski
Ana Carolina Abrantes Mario Henry Rodriguez
Ana Isabel Pinto Màrius V. Fuentes
Ana Vasić Mark F. Wiser
Anamarija Jurcev Savicevic Martina Casenghi
André Pereira Martine Wallon
André Ricardo Araujo da Silva Marwan Osman
Andrea Henriques Pons Matan Shelomi
Andreas Krueger Matteo Angelo Fabris
Andreas Tsatsaris Matteo Ratti
Andrey Sgibnev Matteo Riccò
Ángela María Tobón Max Stephenson, Jr.
Anna M. Timofeeva Md Abu Sayeed
Antonio Camargo Martins Md. Tanvir Rahman
Arturo Carpio Michael Eisenhut
Arturo Sousa Michael Zieger
Aung Kyaw Kyaw Michal Křupka
Baohua Chen Michele E. Murdoch
Basem Battah Michelle Dziejman
Basil Barth Duwa Miguel Mauricio Cabada
Beatrice Mahler Mihaela Kavran
Bernice N. Harris Minu Chaudhuri
Bilali I. Kabula Mitchell Smith
Biljana Nikolić Mohamed Lounis
Boris Filipović-Grčić Monica Florin-Christensen
Caleb Mpyet Mubarak S. Karsany
Camelia Vidita Gurban Muhammad N. Mahmood
Carlo Contini Münir Aktaş
Carlo Pallotto Nadeem Ullah
Carlos F. Marina Nadia Gabr Ali
Carlos Silva Namrata Anand
Carrie Innes Naseer Iqbal
Cassiano Victoria Negrut Nicoleta
Catherine Forconi Nicola Magnavita
Célia Nogueira Nidia Arechiga-Ceballos
Cesar Augusto Roque-Borda Nilakshi Barua
Charalampos D. Moschopoulos Nils Pilotte
Chayu Yang Nina Mendez-Dominguez
Choo Hock Tan Nora Beatriz Molina
Cinzia Auriti Oleksii Skorokhod
Corien Swaan Olga L. Voronina
Cyrille Blondet Olivier Mukuku
Danica Bogunović Ori Wand
Daniel Cardoso Portela Câmara Osman Aktaş
Daniele Mengato Panagiotis Karanis
Deepak Subedi Pavle Banovic
Deepani Fernando Pavlo Petakh
De-Hua Lai Pedro Ferreira
Denis Sereno Petros Ioannou
Dimtrios Basoulis Philip T. LoVerde
Dina Coertzen Ping Ren
Dirceu Guilherme de Souza Ramos Popchai Ngamskulrungroj
Dmitry Verbenko Pradeep Kumar
Duygu Sari-Ak Pyae Linn Aung
Eduardo Gonçalves Paterson Fox Qingsen Shang
Ehsan Ahmadpour Rachel Schambow
Eleftheria Hatzidaki Radha Gopalaswamy
Elena Tarca Raja Veerapandian
Eleni Patsoula Rajdeep Banerjee
Elham Kazemirad Raktham Mektrirat
Eliete Caló Romero Ramcés Falfán-Valencia
Elsy Beatriz Canché-Pool Ramendra Pati Pandey
Emelyn Salazar Rania M. S. El-Malt
Emmanuel Balogun Razique Anwer
Engin Berber Renata Heisler Neves
Enos Moyo Reshmi Dassaye
Fabiana Superti Riccardo Moretti
Fabio Fiorino Robert Bransfield
Fabrício S. Campos Rodolfo Lagunes-Quintanilla
Fabrizio Bertelloni Rohit Singh
Fauna Herawati Ronald J. Ellis
Felipe Masiero Salvarani Rosilainy Surubi Fernandes
Fernando P. Monroy Rubén L. Rodríguez-Expósito
Flor H. Pujol Ruchi Singh
Francisco Espinoza-Gomez Rumen Harizanov
Francisco José Barbas Rodrigues Rupak Nagraik
Gabriel Augusto Marques Rossi Salahuddin
Gerard Goh Sameer Tiwari
Gilberto Gonzalez-Parra Samia Boussaa
Giorgio Sodero Samuel Duodu
Giovanni Cicceri Sandeep R. Kaushik
Giuseppe Di Martino Sanjin Kovacevic
Gongzhen Liu Santanu Sasidharan
Guillermo Salgado-Maldonado Sashank Kolli
Gunapati Bhargavi Selvakumar Subbian
Gustavo Rodrigues Makert Dos Santos Serena Cavallero
Halilibrahim Ciftci Severo Vázquez Prieto
Hazir Rahman Shawky M. Aboelhadid
Héctor Gabriel Avila Silas Wintuma Avicor
Herman J. Woerdenbag Simon Smith
Hisham Ahmed Imad Sonia Cheetham
Hitesh Chopra Sorin Morariu
Hongbo Zheng Stefan Geiger
Hülya Şimşek Stefano Rusconi
Huseyin Cetin Stjepan Krčmar
Ian Hodgson Styliani Geronikolou
Igor Oscorbin Suman Lata Wattal
Inna Solyanikova Suman Sundar Mohanty
Irene Molina-de la Fuente Suraj N. Mali
Isabel L. Maurício Susan Cork
Isabele Angelo Susan Madison-Antenucci
Ivo Sirakov Takaomi Arai
Jack Mchugh Tania Pencheva
Jacob Lorenzo-Morales Tao Li
Jader De Oliveira Tatjana Vilibic-Cavlek
Jairo Lizarazo Telma Sousa
Jaishree Raman Teresa Letra Mateus
Jan Rychtar ThankGod E. Onyiche
Jara Llenas-García Tim Hulsen
Jari Intra Ting Zhang
Jenna E. Coalson Tommaso Bellini
Jiayue Yan Tsz Ho Kwan
Joanna Dąbrowska Tuba Çiğdem Oğuzoğlu
Joeri Jan Pen Uriel Koziol
John Hawdon Ursula Panzner
Jorg Heukelbach Vera A. Alferova
José Artur Bogo Chies Víctor José González Ramallo
Joseph Servadio Vinícius Silva Belo
Josipa Skelin Vishwanath Jha
Juan Alberto Corbera Waqas Ahmad
Junyan Liu Wilbert Gobbo
Kanok Preativatanyou William Hoyos
Karel Allegaert Xinye Chen
Karla Bitencourth Yanhua Li
Katarzyna Napiórkowska-Baran Yasser Helmy Mohamed
Kayode Oshinubi Yolandy Lemmer
Kazuki Ide Yun Ji
Kentaro Kato Zeeshan Nawaz
Kharleezelle Moendeg-Mamades Zenon Pogorelić
Kiran Avula Zhiwei Yang
Krzysztof Korzeniewski Zia Ud Din Sindhu
Kuan Hua Khor Zi-Guo Yuan

24 January 2025
World Leprosy Day 2025—Unite. Act. Eliminate.


World Leprosy Day is a global awareness initiative aimed at shedding light on the ongoing challenges posed by leprosy, a curable disease that still affects thousands annually. This day also emphasizes the collective responsibility to eliminate stigma, promote dignity, and ensure equitable access to healthcare for individuals and communities impacted by leprosy. It serves as a reminder of the importance of early detection, effective treatment, and global cooperation in addressing this neglected tropical disease.

In recognition of World Leprosy Day 2025, we invite you to explore selected articles, Special Issues, and journals such as Pathogens, Microbiology Research, Diseases, Healthcare and Tropical Medicine and Infectious Disease. By fostering collaboration and sharing knowledge, we aim to inspire positive action and contribute to a future where leprosy is no longer a public health concern, and all individuals affected by it can live with dignity and acceptance.

 

The Safety, Acceptability, and Feasibility of Single-Dose Rifampicin as Post-Exposure Chemoprophylaxis for Contacts of Leprosy Patients in Togo: A Mixed-Method Sequential Explanatory Study
by Akila Wimima Bakoubayi, Falapalaki Haliba, Wendpouiré Ida C. Zida-Compaore, P’tanam P’kontème Bando, Yao Rodion Konu, Abissouwèssim Egbare Tchade, Kodjo Akpadja, Kamevor Alaglo, Maweke Tchalim, P’niwè Patchali et al.
Trop. Med. Infect. Dis. 2024, 9(11), 276; https://doi.org/10.3390/tropicalmed9110276

Genomic and Phenotypic Variations Among Thai-53 and Mycobacterium leprae Clinical Isolates: Implications for Leprosy Pathogenesis and Research
by Tiago Araujo Gomes, Tatiana Pereira da Silva, Edson Machado, Sidra Ezidio Gonçalves Vasconcelos, Bruno Siqueira Mietto, Daniela Ferreira de Faria Bertoluci, Patricia Sammarco Rosa, Roberta Olmo Pinheiro, Philip Noel Suffys, Letícia Miranda Santos Lery et al.
Pathogens 2024, 13(11), 986; https://doi.org/10.3390/pathogens13110986

Human Skin as an Ex Vivo Model for Maintaining Mycobacterium leprae and Leprosy Studies
by Natália Aparecida de Paula, Marcel Nani Leite, Daniele Ferreira de Faria Bertoluci, Cleverson Teixeira Soares, Patrícia Sammarco Rosa and Marco Andrey Cipriani Frade
Trop. Med. Infect. Dis. 2024, 9(6), 135; https://doi.org/10.3390/tropicalmed9060135

Training and Active Case Detection to Prevent Leprosy: Effect on Knowledge, Attitude and Skills of Health Workers on Early Diagnosis of Leprosy in a Leprosy Hotspot District in Ethiopia
by Ephrem Mamo, Dareskedar Tsehay, Seid Hassen, Solomon Getahun, Addis Mengiste, Beletshachew Tadesse, Tesfaye Tadesse, Mengestu Legesse and Kidist Bobosha
Trop. Med. Infect. Dis. 2024, 9(3), 51; https://doi.org/10.3390/tropicalmed9030051

Self-Care Ability and Life Quality of Cured Leprosy Patients: The Mediating Effects of Social Support
by Li Xu, Guangjie Jin, Xiang Li, Yuting Shao,Yunhui Li and Lianhua Zhang
Healthcare 2023, 11(23), 3059; https://doi.org/10.3390/healthcare11233059

Immunohistochemical Characterization of M1, M2, and M4 Macrophages in Leprosy Skin Lesions”
by Tatiane Costa Quaresma, Lívia de Aguiar Valentim, Jorge Rodrigues de Sousa, Tinara Leila de Souza Aarão, Hellen Thais Fuzii, Maria Irma Seixas Duarte, Juarez de Souza and Juarez Antônio Simões Quaresma
Pathogens 2023, 12(10), 1225; https://doi.org/10.3390/pathogens12101225

Potassium-Incorporated Titanium Oxide Nanoparticles Modulate Human Dendritic Cell Immune Response to Mycobacterium leprae
by Sam Warren, So Yoon Lee, Jose Barraga, Piya Kositangool, Hatsuko Yoshikubo and Jorge Cervantes
Microbiol. Res. 2023, 14(2), 787-797; https://doi.org/10.3390/microbiolres14020055

Meaningful Engagement of Persons Affected by Leprosy in Research: An Exploration of Its Interpretation, Barriers, and Opportunities
by Laura de Groot, Anna T. van ‘t Noordende, Mathias Duck, Joshua Oraga, Sarju Sing Rai, Ruth M. H. Peters and Nienke Veldhuijzen
Trop. Med. Infect. Dis. 2023, 8(1), 52; https://doi.org/10.3390/tropicalmed8010052

Infectious Disease Prevention and Public Health Promotion: Second Edition

Towards Zero Leprosy: Epidemiology and Prevention Strategy

Epidemiological Trends and Risk Factors in Geriatric and Infectious Diseases

Advances in Molecular Diagnosis in Neglected Tropical Diseases

21 January 2025
MDPI’s Newly Launched Journals in December 2024

Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)


Prof. Dr. Zhaoyang Dong
City University of Hong Kong, China
Editorial | View inaugural issue

energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage
View journal scope | Submit an article

Prof. Dr. Yang-Hui He
1. London Institute for Mathematical Sciences, Royal Institution, UK
2. University of Oxford, UK
Editorial | View inaugural issue
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory;  convex geometry
View journal scope | Submit an article

Dr. Michel Planat
Université de Franche-Comté, France
Editorial | View inaugural issue
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets
View journal scope | Submit an article

Prof. Dr. Rashid Al Abri
1. Sultan Qaboos University, Oman
2. Oman Medical Association, Oman
Editorial | View inaugural issue
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety
View journal scope | Submit an article

Prof. Dr. Ecevit Bilgili*
New Jersey Institute of Technology, USA
*Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration.
Editorial | View inaugural issue
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production
View journal scope | Submit an article

Dr. Weiyong Liu
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry
View journal scope | Submit an article

Prof. Dr. Manuel Pedro Rodríguez Bolívar
University of Granada, Spain
Editorial | View inaugural issue
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation
View journal scope | Submit an article

Prof. Dr. Fei Fan
Wuhan University, Wuhan 430072, China
Editorial | View inaugural issue
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice
View journal scope | Submit an article

Dr. Kevin Cianfaglione
Université Catholique de Lille, France
Editorial | View inaugural issue
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation
View journal scope | Submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflecting on 2024: Celebrating Our Progress and People

As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.

Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.

Looking for a new role in 2025? We have a variety of roles currently open!

Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.

These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.

On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.

Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.

“MDPI thrives because of community and collaboration”

When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.

As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.

Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.

PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.

Impactful Research

685 MDPI Editors Named Highly Cited Researchers in 2024

I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.

Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.

Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.

As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.

I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.

Inside MDPI

How MDPI / Open Access Supports Societies

MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.

Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.

Learn about how MDPI / Open Access Supports Societies.

In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.

If you would like to learn more about these services, please see the Societies website.

The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.

How long have you been at MDPI, and what was your first role?

I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team. 

Do you think that perceptions of Open Access are generally accurate?

Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards. 

How long have you been at MDPI, and what was your first role?

I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.

What is the most common question you get asked about the services that the Societies team provides?

For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.  

For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.

Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.

Read more:

Coming Together for Science

2024 MDPI Conference Summary

Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.

The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.

2024 Event Highlights

Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.

Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’

Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’

A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.

The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.

ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.

The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.

Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.

In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.

The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.

Scheduled Events in 2025

Closing Thoughts

Over 100 German Universities Partner with MDPI in New National Agreement  

I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.

This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.

Learn more, here.

“Thank you to everyone who contributed to making this agreement a reality.”

Why is this important?

Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.

This agreement reflects our growing influence and leadership in open access publishing.

Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.

As Peter Roth, MDPI Head of Publishing, noted:

“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.” 

Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:

“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform” 

Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.

Stefan Tochev
Chief Executive Officer
MDPI AG

Back to TopTop